House sub­com­mit­tee ad­vances 10% bud­get in­crease for FDA in 2023

A House ap­pro­pri­a­tions sub­com­mit­tee ad­vanced via voice vote a new spend­ing bill for the FDA yes­ter­day, of­fer­ing $3.6 bil­lion in dis­cre­tionary fund­ing (i.e. not user fees), which is a 10% in­crease from this year and a $3 mil­lion in­crease over the agency’s re­quest.

Some of that in­crease, the com­mit­tee said, or $64 mil­lion will be di­rect­ed at the agency’s work on the opi­oid cri­sis, as CDC cit­ed over 100,000 over­dos­es in 2021, as well as med­ical sup­ply chain sur­veil­lance, drug safe­ty over­sight, and in­creas­ing and strength­en­ing in-per­son in­spec­tions of drug man­u­fac­tur­ers in In­dia, specif­i­cal­ly. The agency al­so will get $50 mil­lion in funds as part of the im­ple­men­ta­tion of the 21st Cen­tu­ry Cures Act.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER